Overview
Hypermagnesemia is an uncommon clinical finding, and symptomatic hypermagnesemia is even less common. This disorder has a low incidence of occurrence, because the kidney is able to eliminate excess magnesium by rapidly reducing its tubular reabsorption to almost negligible amounts.
In healthy adults, plasma magnesium ranges from 1.7-2.3 mg/dL. Approximately 30% of total plasma magnesium is protein-bound and approximately 70% is filterable through artificial membranes (15% complexed, 55% free Mg2+ ions). With a glomerular filtration rate (GFR) of approximately 150 L per day and an ultrafiltrable magnesium concentration of 14 mg/L, the filtered magnesium load is approximately 2,100 mg per day. Normally, only 3% of filtered magnesium appears in urine; thus, 97% is reabsorbed by the renal tubules. In contrast to sodium and calcium, only approximately 25-30% of filtered magnesium is reabsorbed in the proximal tubule. Approximately 60-65% of filtered magnesium is reabsorbed in the thick ascending loop of Henle and 5% is reabsorbed in the distal nephron.[1] Relatively little is known about cellular magnesium transport mechanisms.[2]
The most common cause of hypermagnesemia is renal failure. Other causes include the following[3, 4] :
- Excessive intake
- Lithium therapy
- Hypothyroidism
- Addison disease
- Familial hypocalciuric hypercalcemia
- Milk alkali syndrome
- Depression
Renal Failure
Patients with end-stage renal disease often have mild hypermagnesemia, and the ingestion of magnesium-containing medications (eg, antacids, cathartics) can exacerbate the condition. In patients undergoing regular dialysis, the serum magnesium level directly relates to the dialysate magnesium concentration.[5]
In patients with acute renal failure, hypermagnesemia usually presents during the oliguric phase; the serum magnesium level returns to normal during the diuretic phase. If a patient receives exogenous magnesium during the oliguric phase, severe hypermagnesemia can result, especially if the patient is acidotic.
Other Causes
People often take magnesium-containing medications (eg, antacids, laxatives,[6] rectal enemas). Hypermagnesemia can develop after treatment of drug overdoses with magnesium-containing cathartics,[7] and it also occurs in patients taking magnesium-containing medications for therapeutic purposes[8, 9] ; however, most of these patients have normal renal function. If the patient does not ingest a large amount of magnesium but has a gastrointestinal disorder (eg, gastritis, colitis, gastric dilation), absorption may increase.[10, 11] In any case, monitoring serum magnesium levels in patients taking magnesium-containing medications is prudent.
Excessive tissue breakdown (sepsis, shock, large burns), especially with concurrent renal failure, can deliver a large amount of magnesium from the intracellular space, along with a massive elevation of phosphorus and potassium.[4]
In the treatment of eclampsia, hypermagnesemia is induced deliberately and sometimes can be symptomatic.[8, 12, 13] Occasionally, hypermagnesemia also can occur in the newborn infant.[14, 15] Maternal magnesium therapy can cause neurobehavioral disorders in the newborn.[16]
Magnesium-containing phosphorus binders are rarely used in end-stage renal disease patients[17, 18] and can lead to elevated magnesium levels.
Lithium therapy causes hypermagnesemia by decreasing urinary excretion, although the mechanism for this is not completely clear.
Familial hypocalciuric hypercalcemia may cause modest elevations in serum magnesium.[19] This autosomal dominant disorder is characterized by very low excretion of calcium and magnesium and by a normal parathyroid hormone level. Abnormalities of calcium and magnesium handling are due to mutations in the calcium-sensing receptor,[20] resulting in increased magnesium reabsorption in the loop of Henle.
Hypothyroidism, adrenal insufficiency, milk-alkali syndrome[3, 4] and theophylline intoxication occasionally produce mild elevations of serum magnesium.
There has been some interest in the use of magnesium in the treatment and prevention of cardiac arrhythmias and in the treatment of subarachnoid hemorrhage[21, 22] ; however, significant hypermagnesemia has not been reported in these settings.
Effects of Hypermagnesemia
Symptoms of hypermagnesemia usually are not apparent unless the serum magnesium level is greater than 2 mmol/L. Concomitant hypocalcemia, hyperkalemia, or uremia exaggerate the symptoms of hypermagnesemia at any given level.
Neuromuscular symptoms
These are the most common presenting problems. Hypermagnesemia causes blockage of neuromuscular transmission by preventing presynaptic acetylcholine release and by competitively inhibiting calcium influx into the presynaptic nerve channels via the voltage-dependent calcium channel.[23]
One of the earliest symptoms of hypermagnesemia is deep-tendon reflex attenuation. Facial paresthesias also may occur at moderate serum levels.
Muscle weakness is a more severe manifestation, occurring at levels greater than 5 mmol/L. This manifestation can result in flaccid muscle paralysis and depressed respiration and can eventually progress to apnea.
Conduction system symptoms
Hypermagnesemia depresses the conduction system of the heart and sympathetic ganglia.[23] A moderate increase in serum magnesium can lead to a mild decrease in blood pressure, and a greater concentration may cause severe symptomatic hypotension. Magnesium is also cardiotoxic and, in high concentrations, can cause bradycardia. Occasionally, complete heart block and cardiac arrest may occur at levels greater than 7 mmol/L.
Hypocalcemia
Apparently, hypocalcemia results from a decrease in the secretion of parathyroid hormone (PTH) or from end-organ resistance to PTH.[24] Paralytic ileus develops from smooth-muscle paralysis,[10] and mothers being treated with magnesium for preterm labor suppression are at risk.[25]
Hypermagnesemia may interfere with blood clotting through interference with platelet adhesiveness, thrombin generation time, and clotting time.
Nonspecific symptoms
These symptoms include nausea, vomiting, and cutaneous flushing.
Diagnosis and Summary
Hypermagnesemia usually results from a combination of excess magnesium intake and a coexisting impairment of renal function. Diagnosis is usually straightforward and involves measuring serum magnesium levels, as many cases are unsuspected.[26] If a magnesium level is not immediately available, a clue to the existence of hypermagnesemia would be the disease context (preeclampsia, renal failure), the presence of magnesium-containing preparations, or a decreased anion gap.
Quamme GA. Control of magnesium transport in the thick ascending limb. Am J Physiol. Feb 1989;256(2 Pt 2):F197-210. [Medline].
Musso CG. Magnesium metabolism in health and disease. Int Urol Nephrol. Mar 10 2009;[Medline].
Drueke TB, Lacour B. Disorders of calcium, phosphate and magnesium metabolism. In: Feehally J, Floege J, Johnson RJ, eds. Comprehensive Clinical Nephrology. 3rd ed. Philadelphia, Pa: Mosby; 2007:137-8.
Bringhurst FR, Demay MB, Krane SM, et al. Bone and mineral metabolism in health and disease/hypermagnesemia. In: Kasper DL, et al, eds. Harrison's Principles of Internal Medicine. 16th ed. New York, NY: McGraw-Hill; 2005:2245.
Navarro-Gonzalez JF, Mora-Fernandez C, Garcia-Perez J. Clinical implications of disordered magnesium homeostasis in chronic renal failure and dialysis. Semin Dial. Jan-Feb 2009;22(1):37-44. [Medline].
Corbi G, Acanfora D, Iannuzzi GL, et al. Hypermagnesemia predicts mortality in elderly with congestive heart disease: relationship with laxative and antacid use. Rejuvenation Res. Feb 2008;11(1):129-38. [Medline].
Woodard JA, Shannon M, Lacouture PG, et al. Serum magnesium concentrations after repetitive magnesium cathartic administration. Am J Emerg Med. Jul 1990;8(4):297-300. [Medline].
Swain R, Kaplan-Machlis B. Magnesium for the next millennium. South Med J. Nov 1999;92(11):1040-7. [Medline].
So M, Ito H, Sobue K, et al. Circulatory collapse caused by unnoticed hypermagnesemia in a hospitalized patient. J Anesth. 2007;21(2):273-6. [Medline].
Clark BA, Brown RS. Unsuspected morbid hypermagnesemia in elderly patients. Am J Nephrol. 1992;12(5):336-43. [Medline].
Leong DP, Kleinig TJ, Kimber TE, Bardy PG. Severe hypermagnesaemia related to laxative use in acute gastrointestinal graft-versus-host disease. Bone Marrow Transplant. Jul 2006;38(1):71-2. [Medline].
Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet. Jun 10 1995;345(8963):1455-63. [Medline].
Toyoshima K, Momma K, Nakanishi T. Fetal reversed constrictive effect of indomethacin and postnatal delayed closure of the ductus arteriosus following administration of transplacental magnesium sulfate in rats. Neonatology. Mar 12 2009;96(2):125-131. [Medline].
Donovan EF, Tsang RC, Steichen JJ, et al. Neonatal hypermagnesemia: effect on parathyroid hormone and calcium homeostasis. J Pediatr. Feb 1980;96(2):305-10. [Medline].
Hyun HS, Choi HS, Kim JK, Ahn SY, Yoo HS, Kim ES, et al. Idiopathic severe hypermagnesemia in an extremely low birth weight infant on the first day of life. Korean J Pediatr. Jul 2011;54(7):310-2. [Medline]. [Full Text].
Rasch DK, Huber PA, Richardson CJ, et al. Neurobehavioral effects of neonatal hypermagnesemia. J Pediatr. Feb 1982;100(2):272-6. [Medline].
Tzanakis IP, Papadaki AN, Wei M, et al. Magnesium carbonate for phosphate control in patients on hemodialysis. A randomized controlled trial. Int Urol Nephrol. 2008;40(1):193-201. [Medline]. [Full Text].
Wyskida K, Witkowicz J, Chudek J, Wiecek A. Daily magnesium intake and hypermagnesemia in hemodialysis patients with chronic kidney disease. J Ren Nutr. Jan 2012;22(1):19-26. [Medline].
Law WM Jr, Heath H 3rd. Familial benign hypercalcemia (hypocalciuric hypercalcemia). Clinical and pathogenetic studies in 21 families. Ann Intern Med. Apr 1985;102(4):511-9. [Medline].
Pearce SH, Trump D, Wooding C, et al. Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. J Clin Invest. Dec 1995;96(6):2683-92. [Medline]. [Full Text].
Schmid-Elsaesser R, Kunz M, Zausinger S, et al. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study. Neurosurgery. Jun 2006;58(6):1054-65; discussion 1054-65. [Medline].
Arango MF, Mejia-Mantilla JH. Magnesium for acute traumatic brain injury. Cochrane Database Syst Rev. Oct 18 2006;CD005400. [Medline].
Agus ZS, Morad M. Modulation of cardiac ion channels by magnesium. Annu Rev Physiol. 1991;53:299-307. [Medline].
Cholst IN, Steinberg SF, Tropper PJ, et al. The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects. N Engl J Med. May 10 1984;310(19):1221-5. [Medline].
Cruikshank DP, Pitkin RM, Reynolds WA, et al. Effects of magnesium sulfate treatment on perinatal calcium metabolism. I. Maternal and fetal responses. Am J Obstet Gynecol. Jun 1 1979;134(3):243-9. [Medline].
Whang R, Ryder KW. Frequency of hypomagnesemia and hypermagnesemia. Requested vs routine. JAMA. Jun 13 1990;263(22):3063-4. [Medline].

